Stay updated on Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for a phase 2 study of pembrolizumab and pelareorep for advanced pancreatic cancer. It includes the study’s terminated status, results, eligibility criteria, treatment plan, outcome measures, and a link to its protocol and statistical analysis plan.
    Difference
    56%
    Check dated 2026-11-09T13:48:56.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer's site revision label changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:43:02.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A notice was added announcing NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T16:36:03.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov 403 Forbidden page; the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-19T17:18:24.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T18:18:31.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden screen instead of the study details, indicating the study record cannot be accessed at this time.
    Difference
    20%
    Check dated 2026-09-21T22:47:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Pelareorep in Advanced Pancreatic Cancer Clinical Trial page.